Researchers developed the seats to measure biometrics during ‘natural’ processes
With 1 million new cases of congestive heart failure diagnosed each year, a revolutionary product is making it easier for hospitals to monitor patients with the condition in the comfort of their own homes.
A toilet-seat based cardiovascular monitoring system created by a team of Rochester Institute of Technology researchers, aims to lower the hospital readmission rates of patients with congestive heart failure. The toilet seats, which will be brought through the FDA clearance process by the researchers’ company Heart Health Intelligence, would be purchased by hospitals and issued to heart failure patients after discharge. The toilet seats are equipped to measure the electrical and mechanical activity of the heart, and can monitor heart rate, blood pressure, blood oxygenation levels, and the patient’s weight and stroke volume, which is the amount of blood pumped out of the heart at every beat. Algorithms analyze the data, and with further development, will alert advanced practice providers of a deteriorating condition. A report will be passed along to cardiologists who will then determine if intervention is necessary.
Nicholas Conn, a postdoctoral fellow at RIT and founder and CEO of Heart Health Intelligence, is part of the university team that developed the toilet seats.
“Typically, within 30 days of hospital discharge, 25 percent of patients with congestive heart failure are readmitted,” said Conn. “After 90 days of hospital discharge, 45 percent of patients are readmitted. And the Centers for Medicare and Medicaid Services is penalizing hospitals for readmitting patients for heart failure.”
Conn, the company’s chief executive officer, further explains that using the national average for readmission rates, the penalty alone for readmitting 150 patients is approximately $500,000 annually. The total cost of providing 150 patients with their own monitored toilet seats from HHI is $200,000. With that investment, he says, hospital systems will save more than double their initial investment within one year.
According to Conn, who earned three degrees from RIT—a bachelor’s degree and a master’s degree in electrical engineering in 2011 and 2013, respectively, and a doctoral degree in microsystems engineering in 2016—the system will pick up deteriorating conditions before the patients even realize they are symptomatic. And with the rapid data analysis, interventions can be as simple as a drug change or short office visit, instead of an admission to the hospital.
HHI, which joined RIT’s Venture Creations business incubator earlier this year, is now focused on moving the product forward. The team is heavily involved in writing grants for additional funding and networking, and human-subject testing and pre-clinical studies are well underway. Conn and his team are working on approving the product with the FDA and rolling it out across the country.
The Latest on: Congestive heart failure
via Google News
The Latest on: Congestive heart failure
- InCarda Therapeutics Announces Enrollment of First U.S. Patient in Phase 2 INSTANT Trial of ...on January 19, 2021 at 10:04 pm
(GLOBE NEWSWIRE) -- InCarda Therapeutics, Inc. (“InCarda”), a privately-held biopharmaceutical company developing first-of-their-kind inhaled therapies for cardiovascular diseases, today announced ...
- Portland telehealth startup Conversa raises $8Mon January 19, 2021 at 10:39 am
Conversa, a Portland, Ore.-based telehealth startup, has raised another $8 million as part of an expanded Series B round. The company announced a $12 million round in June co-led by Builders VC ...
- When COVID Deaths Aren't Counted, Families Pay the Priceon January 17, 2021 at 4:00 am
When Gwendolyn Davis received her husband's death certificate, she was taken aback. The causes of death? Sepsis and renal failure. No mention of covid-19.
- Cardiac Biomarkers Market To Reach USD 15.77 Billion | Global Industry Outlook, Statistics, Segmentation and Forecast to 2027on January 15, 2021 at 6:08 am
Increase in the prevalence of cardiac diseases and collaborations for product launches are key factors responsible for high CAGR of cardiac biomarkers ...
- Apabetalone’s Positive Effect on Hospitalized Patients Involving Heart Failureon January 12, 2021 at 11:01 pm
(“Resverlogix” or the “Company”) (TSX:RVX) announced today the recent publication of an article titled: “Apabetalone and hospitalization for heart failure in patients following an acute coronary ...
- Post-COVID-19 myocarditis can afflict anyone — including highly conditioned athleteson January 12, 2021 at 4:38 pm
Players from both teams — many of whom have known and competed with and against each other since their earliest youth league days — were visibly shaken. Johnson — the Southeastern Conference Preseason ...
- What Is Brown Fat? People With BAT Possibly At Lower Risk Of Diabetes, Heart Diseaseson January 8, 2021 at 4:00 am
Brown fat gets stored in people's neck and shoulders Scientists have been working to have a better understanding of brown fat Researchers found the prevalence of cardiometabolic diseases was low in ...
- Congestive Heart Failure Drugs Market 2020 Global Trend, Segmentation and Opportunities Forecast To 2026on January 6, 2021 at 5:10 am
New Study Reports "Congestive Heart Failure Drugs Market 2020 Global Market Opportunities, Challenges, Strategies and Forecasts 2026" has been Added on WiseGuyReports. This report provides in depth ...
- Ask the Doctors: Congestive heart failure; what to expecton December 26, 2020 at 9:32 pm
Dear Doctors: Our grandfather was diagnosed with congestive heart failure a few years ago. His strength and endurance have declined a lot, and now he's on oxygen. What are some of the signs that ...
- I missed the warning signs of congestive heart failure because I was so busy and stressed. Here's what I hope other working moms can learn from my example.on December 25, 2020 at 7:30 am
The doctor told me I had pulmonary edema, a condition where your lungs fill with fluid, and that I was in congestive heart failure. There I was. A 34-year-old woman, sitting alone in the emergency ...
via Bing News